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Abstract: Endogenous prostaglandin (PG) E2 plays important roles in renal homeostasis. Immunoexpressions of PGE2 
biosynthesis-related enzymes, cyclooxygenase (COX)-2 and microsomal PGE2 synthetase (mPGES)-1 and EP4 (a PGE2 
receptor), were investigated in renal development. Kidney tissues were obtained from fetuses on gestation days 18 and 21 
and neonates on days 1 to 18. In fetuses and early neonates, the expressions of COX-2, mPGES-1 and EP4 were observed 
in developing renal tubules, indicating that COX-2 and its product, PGE2, play important roles in blastemal cell-derived 
renal tubular development via EP4. Cyclin D1 expression was seen in both the nucleus and cytoplasm of the developing 
tubules. These findings differed from the decreased COX-2 expression and exclusive nuclear expression of cyclin D1 
seen in abnormal epithelial regeneration of injured renal tubules in cisplatin-treated rats in our previous articles. Col-
lectively, PGE2, induced by COX-2, regulates renal tubular epithelial formation via EP4. (DOI: 10.1293/tox.24.257; J 
Toxicol Pathol 2011; 24: 257–261)
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Prostaglandin (PG), mainly PGE2, plays important 
roles in renal hemodynamics, renin release and salt and 
water homeostasis1,2. The PGE2 is synthesized from arachi-
donic acid; first, arachidonic acid is converted to an unsta-
ble intermediate PGH2 by cyclooxygenase (COX). PGH2 is 
converted to PGE2 by prostaglandin E synthase (PGES)2,3. 
COX consists of two isoforms, COX-1 and COX-2; COX-1 
is constitutively expressed and responsible for basal PG pro-
duction in relation to homeostasis, whereas COX-2 is an in-
ducible form that may be primarily associated with inflam-
matory reaction4. In the kidney, however, the expressions 
of COX-1 and COX-2 are constitutively seen, and they play 
important roles in renal homeostasis5,6. The activity of PGE2 
is mediated through four different receptor subtypes: EP1, 
EP2, EP3 and EP4. EP1 is associated with calcium mobiliza-
tion, EP2 and EP4 are associated with stimulation of adenyl-
ate cyclase (AC) and EP3 is associated with inhibition of AC 
or with stimulation of phosphoinositol turnover1.
Previously, we showed that endogenous PGE2 partici-
pated in abnormal regeneration of renal tubular epithelial 
cells after injury induced in rats by cisplatin (CDDP) ex-
clusively through EP47. We considered that regeneration of 
renal tubules after injury recapitulates development pro-
cesses in nephrogenesis8. To shed some light on renal tubu-
lar regeneration after CDDP injury, in the present study, we 
investigated expression patterns of main PGE2 biosynthe-
sis-related enzymes, COX-2 and microsomal PGES (mPG-
ES)-1, as well as EP4 in rat nephrogenesis. PGE2 may affect 
the G1 phase of the cell cycle of renal tubules through EP47. 
We also examined the expression of cyclin D1, a marker of 
the G1 phase in the cell cycle9.
The following experiments conformed to our institu-
tional guidelines for animal care. Pregnant female F344/
DuCrj rats were obtained from Charles River Laboratories 
Japan (Hino, Shiga, Japan). They were housed in an animal 
room controlled to 22 ± 3 °C with a 12:12-h light-dark cycle 
and were allowed free access to a standard commercial diet 
(MF, Oriental Yeast Co., Ltd., Tokyo) and tap water. The day 
of birth was designated postnatal day 0 (P0). Animals were 
euthanized under deep anesthesia, and kidney tissues were 
obtained from fetuses on gestation days (GDs) 18 and 21, 
as well as neonates on days 1, 3, 6, 9, 12 15 and 18 (at each 
examination point, at least three rat samples were used).
Kidneys were fixed in 10% neutral buffered formalin 
and  periodate-lysine-paraformaldehyde  (PLP)  fixatives. 
Formalin-fixed samples were processed routinely and em-
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bedded in paraffin; PLP solution-fixed specimens were em-
bedded in paraffin by the AMeX method (PLP-AMeX meth-
od)10. Formalin-fixed, paraffin-embedded samples were cut 
at a thickness of 3–4 μm, and stained with hematoxylin-
eosin (HE) for morphology.
For immunohistochemistry, the specimens were cut at 
a thickness of 4-μm, deparaffinized with xylene, rehydrated 
with graded ethanol and washed in water. These sections 
were boiled with microwave for 5 minutes for antigen re-
trieval. They were then treated with 3% H2O2 for 10 minutes 
at room temperature for blocking of endogenous peroxidase. 
Tissue sections were incubated with polyclonal anti-COX-2 
(1:300, Cayman Chemical Company.), polyclonal anti-mP-
GES-1 (1:200, Cayman Chemical Company.), polyclonal 
anti-EP4 (1:500, Upstate Biotechnology Inc.) and mono-
clonal anti-cyclin D1 (1:200, Upstate Biotechnology Inc.) 
for 12–14 hours at 4 °C. Thereafter, sections were washed 
three times with phosphate-buffered saline (PBS) and incu-
bated for 45 minutes with the secondary antibody (Histofine 
Sample Stain MAX PO, Nichirei Corporation, Tokyo, Ja-
pan). Positive reactions were visualized with 3, 3′-diamino-
benzidine (DAB). Sections were lightly counterstained with 
hematoxylin.
Rat nephrogenesis was described previously11. Briefly, 
in fetuses on GDs 18 and 21, loosely arranged blastemal 
cell-derived mesenchymal cells were abundantly observed 
among developing renal tubules and glomeruli in the cor-
tical areas. The developing glomeruli consisted of round-, 
comma- and S-shaped bodies in lineage. The mesenchymal 
cells were gradually decreased with age after birth (neo-
nates). Instead, maturing renal tubules and glomeruli be-
came predominant in the cortex and medulla (Fig. 1). In the 
medullary areas of the fetuses on GDs 18 and 21, loosely ar-
ranged mesenchymal cells surrounding the branches of epi-
thelial ureteric tubules were observed. In neonates on days 
1–15, the loosely arranged mesenchymal cells gradually de-
creased; in neonates on day 18, matured renal tubules and 
collecting ducts were developed, and a few mesenchymal 
cells were present in the tubulointerstitium in the medulla.
The immunoexpressions of COX-2 (Fig. 2A), mPGES-1 
(Fig. 3), EP4 (Fig. 4) and cyclin D1 (Fig. 5) were observed 
in the developing tubules (Fig. 2A, 3, 4 and 5) in fetuses and 
early neonates. Except cyclin D1, which was expressed in 
both the nucleus and cytoplasm in the developing tubules 
(Fig. 5), the positive reactions for other antibodies were seen 
in the cytoplasm. As renal development proceeded, the ex-
pression patterns in the renal tubules were close to those of 
adult animals; COX-2 was restricted in the straight tubules 
in the cortex and macula densa (Fig. 2B); mPGES-1 was 
limited in the renal tubules in the medulla, which develop 
into the thin limb of the loop of Henle; cyclin D1 was seen 
only in the nuclei of renal tubular epithelial cells; EP4 was 
restricted in the distal tubules.
In the S-shaped body, immunoreactions for COX-2 
(Fig. 2A), EP4 (Fig. 4) and cyclin D1 (Fig. 5) were observed, 
but that of mPGES-1 was not observed (Fig. 3 inset). In the 
interstitium, mesenchymal cells reacted to EP4 (Fig. 4) and 
cyclin D1 (Fig. 5) in varying degrees.
In metanephric development, mutual induction be-
tween the blastemal mesenchymal cells and epithelial cells 
of the ureteric bub occurs initially; after that, some blas-
temal cell-derived mesenchymal cells form epithelial cells 
of the renal tubules and glomeruli through mesenchymal-
epithelial transition in the cortex, whereas others persist in 
the interstitium and maintain the features of mesenchymal 
cells12. PGE2, which is synthesized from arachidonic acid 
converted by COX-1 or COX-2, has important roles in 
nephrogenesis and homeostasis in the kidneys1,2,13. How-
ever, COX-1 seems not to be essential for renal development 
because no alterations were observed in renal structures in 
COX-1 deficient mice14. On the contrary, COX-2 deficient 
mice exhibit abnormal renal development15,16. As dem-
onstrated in this study, COX-2 expression was seen in the 
developing renal tubules in fetuses and early neonates, in-
dicating participation of COX-2 in development of renal epi-
thelial cells from blastemal cells in fetuses17. Moreover, we 
investigated the expression patterns of mPGES-1, a PGE2 
biosynthesis-related enzyme, and EP4 in developing rat 
kidneys. In agreement with the expression of COX-2, mP-
GES-1 and EP4 were expressed in developing renal tubules 
of fetuses and early neonates. These findings indicate that 
PGE2 can regulate renal tubular epithelial development (in 
Fig. 1.  Histology of nephrogenesis in a neonate on day 1. Developing renal tubules (arrows) and maturing glomeruli (arrowhead) are present. 
HE stain. Bar=100 μm.
Fig. 2.  Immunohistochemical findings for cyclooxygenase (COX)-2 in fetuses on gestation days (GDs) 18 (A) and 21 (B). COX-2 expressions 
are observed in developing renal tubules (arrowhead) and S-shaped bodies (arrow, A) on GD 18 and in the macula densa (arrowhead) of 
juxtamedullary nephrons on GD 21 (B). Immunohistochemical staining, counterstained with hematoxylin. Bar=100 μm.
Fig. 3.  Immunohistochemical findings for microsomal PGE2 synthetase (mPGES)-1 in a neonate on day 1. Expressions of mPGES-1 are ob-
served in the developing tubules (arrowheads), but not in S-shaped bodies (inset: Bar=20 μm). Immunohistochemical staining, counter-
stained with hematoxylin. Bar=100 μm.
Fig. 4.  Immunohistochemical findings for PGE2 receptor (EP) 4 in a fetus on GD 18.  EP4 expressions are observed in the developing renal 
tubules (arrowheads) and S-shaped bodies (arrow), as well as occasional interstitial mesenchymal cells.  Immunohistochemical staining, 
counterstained with hematoxylin.  Bar=100 μm.
Fig. 5.  Immunohistochemical findings for cyclin D1 in a neonate on day 1.  Cyclin D1 expressions are observed in both the nucleus and cytoplasm 
of the developing renal tubule (arrowheads) and S-shaped bodies (arrow), as well as mesenchymal cells.  Immunohistochemical staining, 
counterstained with hematoxylin. Bar=100 μm.The Expression of Endogenous PGE2 in Rat Nephrogenesis  260
developing nephrons) via EP4 and that the PGE2 is induced 
mainly by COX-2. In the S-shaped body, the expressions of 
COX-2, EP4 and cyclin D1 were observed; however, that of 
mPGES-1 was not observed. Because PGES has multiple 
forms, namely mPGES-1, mPGES-2 and cPGES18, other 
forms of PGES might participate in glomerular formation 
from S-shaped bodies. In addition to mesenchymal cells re-
acting to EP4 and cyclin D1, the significance of S-shaped 
body development remains to be pursued further.
Previously, we showed that COX-2 expression was de-
creased in the stage of renal tubule regeneration after CDDP 
injury7. This finding differed from the increased expres-
sion of COX-2 seen in developing renal tubules in the pres-
ent study. Cyclin D1 is a marker of the G1 phase in the cell 
cycle9; the expression is seen in the nucleus in cells at the 
G1 phase and the cytoplasm in cells at the S phase19. The 
epithelial cells in developing renal tubules showed a posi-
tive reaction to cyclin D1 in both the nucleus and cytoplasm, 
which is indicative of normal cell cycle regulation. Because 
the expressions of COX-2 and EP4 were also observed at the 
same site as cyclin D1 expression, COX-2 and its product, 
PGE2, are considered to be involved in normal proliferation 
and cellular differentiation of blastemal cell-derived renal 
tubules through EP4. On the other hand, cyclin D1 expres-
sion was restricted within the nucleus of regenerating renal 
epithelia in CDDP-treated kidneys, suggesting abnormal re-
generation of the affected renal tubules7.
In conclusion, it was found that endogenous PGE2 
plays important roles in nephrogenesis, particularly blas-
temal cell-derived renal tubular development in the cortex, 
via EP4 expression. During development, COX-2 acted as 
an important inducer. Additionally, cyclin D1 expressions 
seen in the epithelial nucleus and cytoplasm indicated nor-
mal proliferation and cellular differentiation in the develop-
ing renal tubules. These findings were different from those 
of CDDP-induced renal lesions, which showed decreased 
COX-2 expression and exclusive nuclear expression of cy-
clin D17,20. We had expected that developing renal tubules 
might reflect epithelial regeneration of CDDP-injured renal 
tubules. The differences between developing renal tubules 
and CDDP-injured renal epithelia might give us some clues 
to pursue the pathogenesis of renal fibrosis after tissue in-
jury.
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